Press Releases

HANGZHOU and SHAOXING, China, Aug. 4, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases, announces today that it received IND approval of ASC18, first one-pill, once-a-day fixed dose c

Read more...

ANAHEIM, Calif., Aug. 4, 2019 /PRNewswire/ -- At the 71st AACC Annual Scientific Meeting & Clinical Lab Expo, laboratory medicine experts will present the cutting-edge research and technology that is revolutionizing clinical testing and patient care. From August 4-8 in Anaheim, California

Read more...

SYDNEY, Aug. 4, 2019 /PRNewswire/ -- Chemist Warehouse today announced its partnership with SmileDirectClub, the US-based teledentistry pioneer, 

Read more...

LAKE MARY, Fla., Aug. 4, 2019 /PRNewswire/ -- VUCA Health announced today that it has partnered with Allen Technologies, an interactive patient engagement solutions provider, to deliver its Med

Read more...

NEEDHAM, Mass., Aug. 3, 2019 /PRNewswire/ -- Today, the Pan-Mass Challenge (PMC) embarked on its 40th ride, with more than 6,700 cyclists from 43 states and 12 countries c

Read more...

OAKLAND, Calif., Aug. 2, 2019 /PRNewswire/ -- Kaiser Permanente has presented a proposal to leadership of the Coalition of Kaiser Permanente Unions that would provide annual pay increases and maintain excellent employee benefits while also creating a program that would seek to reduce the national shortage of health care workers.

Read more...

TOKYO and MUNICH and BASKING RIDGE, N.J., Aug. 2, 2019 /PRNewswire/ -- Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the U.S. Food and Drug Administration (FDA) approved TURALIO™ (pexidartinib) as the first and only treatment for adult patients with

Read more...

NEW YORK, Aug. 2, 2019 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Aclaris Therapeutics, Inc. (NASDAQ: ACRS) from May 8, 2018 through June 20, 2019, inclusive (the "Class Period"). The la

Read more...

MIAMI BEACH, Fla., Aug. 2, 2019 /PRNewswire/ -- Welterweight title contender Colby Covington signs endorsement deal with Cannafornia CBD ahead of his August 3rd UFC on ESPN Main Event Fight.American UFC star Colby Covington signed an en

Read more...